Recursion, a Salt Lake City-based digital biology company industrializing drug discovery, has announced the appointment of R. Martin Chavez as chairman of its board of directors. Chavez, who joined Recursion’s board in 2020, will serve as the company’s first independent chairman. In this role, he will oversee the organization’s goals with regard to investor relations and apply his career-long innovation expertise to support Recursion's mission to decode biology and radically improve lives. His experience includes serving in a variety of senior roles at Goldman Sachs, including chief information officer, chief financial officer and global co-head of the firm’s Securities Division and as a member of Goldman’s management committee; serving as CEO and co-founder of Kiodex; and serving as chief technology officer and co-founder of Quorum Software Systems. He also has served as a senior advisor at Sixth Street Partners and as a board member for Paige, Banco Santander SA and Sema4.